贝伐单抗:一种有争议的治疗高级别胶质瘤的药物

{"title":"贝伐单抗:一种有争议的治疗高级别胶质瘤的药物","authors":"S. Salas, Miguel A. Guzmán, K. Judy","doi":"10.29046/JHNJ.006.2.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":355574,"journal":{"name":"JHN Journal","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Bevacizumab: A Controversial Agent Against High-Grade Gliomas\",\"authors\":\"S. Salas, Miguel A. Guzmán, K. Judy\",\"doi\":\"10.29046/JHNJ.006.2.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":355574,\"journal\":{\"name\":\"JHN Journal\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHN Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29046/JHNJ.006.2.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHN Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29046/JHNJ.006.2.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}